Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 51407-441

4 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 51407-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tec00-0006-01 (Tec00 0006 01)

Tec00-0006-01 (Tec00 0006 01)
Chemical structure of dimethyl fumarate showing its molecular arrangement with labeled oxygen and hydrogen atoms.*
FDA Label Image

Image Description (Dtfclinical)

Image Description (Dtfclinical)
This line graph compares the percentage of subjects with confirmed progression of disability over time in weeks for placebo versus dimethyl fumarate delayed-release capsules 240 mg BID groups. The placebo group shows a higher percentage progressing to disability over 96 weeks compared to the dimethyl fumarate group, illustrating differences in disability progression rates between the two treatments.*
FDA Label Image

51407-442-14.jpg (51407 442 14)

51407-442-14.jpg (51407 442 14)
Label for Dimethyl Fumarate delayed-release capsules, 120 mg strength, in a 14-capsule package. The label includes dosage instructions to take one capsule by mouth twice daily and swallowing the capsule whole. It also states storage guidelines, that the capsule contains color additives including FD&C Yellow No. 5, and includes manufacturer TWi Pharmaceuticals, Inc. and marketer GSMS, Incorporated branding with location in Camarillo, CA.*
FDA Label Image

51407-441-60 (Rev 06-22.jpg)

51407-441-60 (Rev 06-22.jpg)
Dimethyl Fumarate delayed-release capsules label displaying the 240 mg strength. The label notes the package contains 60 capsules and indicates the product is prescription only. It includes dosage instructions, storage conditions, and manufacturer information for TWi Pharmaceuticals, with marketing by GSMS Incorporated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.